Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
Влияние шоковых концентраций ванкомицина на формирование гетерорезистентности у Staphylococcus aureus. / Gostev, V. V.; Sopova, Y. U.V.; Kalinogorskaya, O. S.; Veuzhanina, M. E.; Lazareva, I. V.; Starkova, P. S.; Sidorenko, S. V.
в: Antibiotiki i Khimioterapiya, Том 65, № 9-10, 2020, стр. 3-7.Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
}
TY - JOUR
T1 - Влияние шоковых концентраций ванкомицина на формирование гетерорезистентности у Staphylococcus aureus
AU - Gostev, V. V.
AU - Sopova, Y. U.V.
AU - Kalinogorskaya, O. S.
AU - Veuzhanina, M. E.
AU - Lazareva, I. V.
AU - Starkova, P. S.
AU - Sidorenko, S. V.
N1 - Publisher Copyright: © 2020 Media Sphera Publishing Group. All rights reserved. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2020
Y1 - 2020
N2 - Glycopeptides are the basis of the treatment of infections caused by MRSA (Methicillin-Resistant Staphylococcus aureus). Previously, it was demonstrated that antibiotic tolerant phenotypes are formed during selection of resistance under the influence of high concentrations of antibiotics. The present study uses a similar in vitro selection model with vancomycin. Clinical isolates of MRSA belonging to genetic lines ST8 and ST239, as well as the MSSA (ATCC29213) strain, were included in the experiment. Test isolates were incubated for five hours in a medium with a high concentration of vancomycin (50 μg/ml). Test cultures were grown on the medium without antibiotic for 18 hours after each exposure. A total of ten exposure cycles were performed. Vancomycin was characterized by bacteriostatic action; the proportion of surviving cells after exposure was 70—100%. After selection, there was a slight increase in the MIC to vancomycin (MIC 2 μg/ml), teicoplanin (MIC 1.5-3 μg/ml) and daptomycin (MIC 0.25-2 μg/ml). According to the results of PAP analysis, all strains showed an increase in the area under curve depending on the concentration of vancomycin after selection, while a heteroresistant phenotype (with PAP/AUC > 0.9) was detected in three isolates. All isolates showed walK mutations (T188S, D235N, E261V, V380I, and G223D). Exposure to short-term shock concentrations of vancomycin promotes the formation of heteroresistance in both MRSA and MSSA. Formation of VISA phenotypes is possible during therapy with vancomycin.
AB - Glycopeptides are the basis of the treatment of infections caused by MRSA (Methicillin-Resistant Staphylococcus aureus). Previously, it was demonstrated that antibiotic tolerant phenotypes are formed during selection of resistance under the influence of high concentrations of antibiotics. The present study uses a similar in vitro selection model with vancomycin. Clinical isolates of MRSA belonging to genetic lines ST8 and ST239, as well as the MSSA (ATCC29213) strain, were included in the experiment. Test isolates were incubated for five hours in a medium with a high concentration of vancomycin (50 μg/ml). Test cultures were grown on the medium without antibiotic for 18 hours after each exposure. A total of ten exposure cycles were performed. Vancomycin was characterized by bacteriostatic action; the proportion of surviving cells after exposure was 70—100%. After selection, there was a slight increase in the MIC to vancomycin (MIC 2 μg/ml), teicoplanin (MIC 1.5-3 μg/ml) and daptomycin (MIC 0.25-2 μg/ml). According to the results of PAP analysis, all strains showed an increase in the area under curve depending on the concentration of vancomycin after selection, while a heteroresistant phenotype (with PAP/AUC > 0.9) was detected in three isolates. All isolates showed walK mutations (T188S, D235N, E261V, V380I, and G223D). Exposure to short-term shock concentrations of vancomycin promotes the formation of heteroresistance in both MRSA and MSSA. Formation of VISA phenotypes is possible during therapy with vancomycin.
KW - Heteroresistance
KW - Selection
KW - Staphylococcus aureus
KW - Vancomycin
KW - WalK
UR - http://www.scopus.com/inward/record.url?scp=85102922250&partnerID=8YFLogxK
U2 - 10.37489/0235-2990-2020-65-9-10-3-7
DO - 10.37489/0235-2990-2020-65-9-10-3-7
M3 - статья
AN - SCOPUS:85102922250
VL - 65
SP - 3
EP - 7
JO - АНТИБИОТИКИ И ХИМИОТЕРАПИЯ
JF - АНТИБИОТИКИ И ХИМИОТЕРАПИЯ
SN - 0235-2990
IS - 9-10
ER -
ID: 76806907